Skip to content

China Acute Myocardial Infarction Registry

China Acute Myocardial Infarction Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01874691
Acronym
CAMIRegistry
Enrollment
20000
Registered
2013-06-11
Start date
2013-01-31
Completion date
2016-12-31
Last updated
2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

acute myocardial infarction, China, Registry

Brief summary

This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.

Detailed description

The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI.

Interventions

None listed

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI.

Exclusion criteria

* Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across Chinathe duration of hospital stay, an expected average of 2 weeksDifferent-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.

Secondary

MeasureTime frameDescription
The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals24 hoursIn different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?
provoking factors of Chinese patients with AMI across different areas and different population in China24 hoursThe different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.

Other

MeasureTime frame
the in-hospital cost of Chinese patients with acute myocardial infarctionthe duration of hospital stay, an expected average of 2 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026